Navigation Links
Nonconformity of NOV002 Used in Phase 3 NSCLC Trial Sponsored by Novelos Therapeutics, Inc to NOV002 (Glutoxim(R)), Used in Phase 1/2 NSCLC and all Previous Trials
Date:6/29/2010

SAINT PETERSBURG, June 29, 2010 /PRNewswire/ -- The Company VAM is the developer of product Glutoxim(R) registered in Russia in 1998, registration No. P N002010/01. We possess significant knowledge and experience in manufacturing of this product as well as in the clinical development application of Glutoxim(R). In accordance with an Agreement dated June 20, 2000, the company VAM diligently and successfully transferred all of the "know-how", manufacturing and quality assurance information on the active drug substance and finished injection forms of the product Glutoxim(R) to Novelos Therapeutics, Inc.

Up to October 2005, the active pharmaceutical ingredient used in Glutoxim(R) (US code name NOV002) was synthesized according to the original manufacturing process and technology transferred from the company VAM to Novelos. The original NOV002 (Glutoxim(R)) used in the Phase 1/2 NSCLC and all previous trials met predetermined clinical endpoints and yielded encouraging results.

After the completion of the Phase 3 NSCLC trial and learning that NOV002 had failed to meet clinical endpoints, VAM requested Novelos to provide samples of products used in the Phase 3 trial. At VAM's request, an independent chemical and biological analysis of the samples was performed in the State Technological Institute of Saint-Petersburg and State Research Trial Institute of Military Medicine.

Expert opinions - excerpts[1]

Technological Institute

"On the basis of data generated by the element analysis it is possible to make a conclusion, that all three presented dry samples considerably differ
'/>"/>

SOURCE Pharma Vam
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
3. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
7. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
10. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
11. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... In response to urgent requests from the Deputy Minister ... Leone , Direct Relief delivered two 10-bed medical tents ... of local health workers who contract Ebola while fighting the ... center was constructed for foreign health care workers who may ... local Sierra Leonean health workers. With ...
(Date:12/22/2014)... , Dec. 22, 2014  CytoSorbents Corporation (OTCQB:CTSOD), ... CytoSorb® blood purification technology to help fight deadly ... 28 countries worldwide, today announced the appointment of ... FACS, as its Senior Vice President of Clinical ... Dr. Di Russo is an accomplished ...
(Date:12/22/2014)... 2014 Research and Markets ( http://www.researchandmarkets.com/research/h3xm6q/us ... Self-monitoring Blood Glucose Market" report to their offering. ... This market insight focuses on the developments in the ... States . Reimbursement analysis and the effects of ... more than 73 SMBG meters have been performed, based ...
Breaking Medicine Technology:First Ebola Treatment Unit for Local Health Workers Arrives in Sierra Leone 2CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 2CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 3CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 4CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 5US Self-monitoring Blood Glucose Market 2
... Amgen (NASDAQ: AMGN ) announced today ... will be presented at the 2011 European Multidisciplinary Cancer ...   "The data being presented at the ... to advancing the understanding of cancer and developing novel ...
... ANNAPOLIS, Md., Sept. 22, 2011 PharmAthene, Inc. (NYSE ... decision in its litigation against SIGA Technologies in the ... SIGA in December 2006 citing PharmAthene,s interest in ST-246, ... "We are extremely pleased with the Court,s decision," remarked ...
Cached Medicine Technology:Amgen Highlights Data to be Presented at 2011 European Multidisciplinary Cancer Congress 2Amgen Highlights Data to be Presented at 2011 European Multidisciplinary Cancer Congress 3Amgen Highlights Data to be Presented at 2011 European Multidisciplinary Cancer Congress 4Amgen Highlights Data to be Presented at 2011 European Multidisciplinary Cancer Congress 5Amgen Highlights Data to be Presented at 2011 European Multidisciplinary Cancer Congress 6Amgen Highlights Data to be Presented at 2011 European Multidisciplinary Cancer Congress 7Amgen Highlights Data to be Presented at 2011 European Multidisciplinary Cancer Congress 8Amgen Highlights Data to be Presented at 2011 European Multidisciplinary Cancer Congress 9Amgen Highlights Data to be Presented at 2011 European Multidisciplinary Cancer Congress 10PharmAthene Awarded 50% Profit Split on Worldwide Sales of Smallpox Antiviral Therapy by Delaware Chancery Court 2PharmAthene Awarded 50% Profit Split on Worldwide Sales of Smallpox Antiviral Therapy by Delaware Chancery Court 3
(Date:12/25/2014)... Dallas, TX (PRWEB) December 26, 2014 ... Analysis to 2023” focuses on the current treatment landscape, ... colorectal cancer market. TS-1 is an anti-cancer drug which ... administered orally and is also used for treating gastric ... gimestat and otastat potassium. The drug was first approved ...
(Date:12/25/2014)... 26, 2014 Recently, iFitDress.com, the popular online ... has announced its new selection of black one-shoulder cocktail ... sale now; they are available at discounted prices, up to ... promotion will last for three weeks only. You know, we ... who are interested in our new items can visit our ...
(Date:12/25/2014)... 2014 Recently, BellasDress has ... its wedding dresses. BellasDress has chosen their best-selling lace ... choices for the holiday season. , Now, BellasDress.com ... wedding gowns here at discount prices. The business hopes ... its website. , “All our elegant products ...
(Date:12/25/2014)... 2014 When head lice hits a home ... frenzy to get rid of it while keeping it from ... Gables now have the solution right in their neighborhood: ... Lice Troopers provides full spectrum head lice screening and treatment ... including Sunset, Key Biscayne, Brickell, Coconut Grove, Kendall, Pinecrest and ...
(Date:12/25/2014)... -- The risk of burns from fires and cooking ... be extra cautious, an expert says. "Between Thanksgiving ... in patients coming in with burns," said Dr. Steven ... Burn Center of Stony Brook University Hospital in New ... but if not careful, could quickly turn tragic," Sandoval ...
Breaking Medicine News(10 mins):Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:iFitDress.com: Black One-Shoulder Cocktail Dresses for 2015 2Health News:BellasDress.com’s Christmas Sale: Trendy Wedding Dresses With Big Discounts 2Health News:Coral Gables Florida Gets Ready to Be Lice-Free with Lice Troopers 2Health News:Don't Let Burns Mar Your Holidays 2
... PLAINS, N.Y., Aug. 24 Out With Allergies LLC has announced the ... new weapon for combating swine flu. Available through their website, ... , these stick-on notes are intended to make people more aware ... the flu. These direct message washup labels are anticipated to make sense ...
... , EUGENE, Ore., Aug. 24 The ... , is launching a national campaign to educate people with ... from germs that include the 2009 flu pandemic that is ... of this virus already hitting the United States, Tech-Aid hopes ...
... , , , ... inflammatory process as the common soil in a diverse range of ... article, discusses how foods like cherries may help rheumatoid arthritis or ... "Chronic inflammation is an emerging field," says Dr. David Heber, ...
... SHENZHEN, China, Aug. 24 /PRNewswire-Asia-FirstCall/ -- China Nepstar,Chain Drugstore Ltd. ... largest,retail drugstore chain in China based on the number of ... quarter ended,June 30, 2009. , Financial ... terminated a voting rights assignment agreement,which assigned 30% of the ...
... ... workers, witnesses, and everyone else in New York, personal injury attorneys included, know about drops hidden ... New ... the "Miracle Man" and New York personal injury attorneys would have to agree. It,s extremely rare ...
... , SEATTLE, Aug. 24 Cell Therapeutics, ... Food and Drug Administration (FDA) has accepted and has filed for ... for relapsed or refractory aggressive non-Hodgkin,s lymphoma (NHL). A Prescription Drug ... regarding the review of the pixantrone NDA by September 4th 2009. ...
Cached Medicine News:Health News:Just Out: A Little Piece of Paper That Helps Stop the Spread of Flu! 2Health News:Oregon Company Launches National Campaign to Help Protect People with Intellectual Disabilities from the Swine Flu 2Health News:Battling Inflammation Through Food an Emerging Field 2Health News:China Nepstar Chain Drugstore Reports Second Quarter 2009 Financial Results 2Health News:China Nepstar Chain Drugstore Reports Second Quarter 2009 Financial Results 3Health News:China Nepstar Chain Drugstore Reports Second Quarter 2009 Financial Results 4Health News:China Nepstar Chain Drugstore Reports Second Quarter 2009 Financial Results 5Health News:China Nepstar Chain Drugstore Reports Second Quarter 2009 Financial Results 6Health News:China Nepstar Chain Drugstore Reports Second Quarter 2009 Financial Results 7Health News:China Nepstar Chain Drugstore Reports Second Quarter 2009 Financial Results 8Health News:China Nepstar Chain Drugstore Reports Second Quarter 2009 Financial Results 9Health News:China Nepstar Chain Drugstore Reports Second Quarter 2009 Financial Results 10Health News:China Nepstar Chain Drugstore Reports Second Quarter 2009 Financial Results 11Health News:China Nepstar Chain Drugstore Reports Second Quarter 2009 Financial Results 12Health News:China Nepstar Chain Drugstore Reports Second Quarter 2009 Financial Results 13Health News:A Miracle Man's 30-Foot Fall Leave New York Personal Injury Attorneys Believing in Miracles, too 2Health News:FDA Accepts to File Cell Therapeutics' New Drug Application for Pixantrone 2Health News:FDA Accepts to File Cell Therapeutics' New Drug Application for Pixantrone 3
MD Coder Charge Capture Pocket PC Edition is a charge capture tool. We have integrated the feedback from hospitals and physicians. MD Coder Charge Capture supports both the Palm OS and Pocket PC plat...
... list of disease and code numbers in ... PC PDA or Smartphone. The International Classification ... is based on the World Health Organization's ... ICD-9-CM is the official system of assigning ...
The focus of HandEchart Professional is to offer a practical and basic electronic patient record keeping system that anyone can learn in minutes....
Archimedes is an innovative specialty calculator. Forget having to remember complicated formulas, just enter the values and out come the results....
Medicine Products: